Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.

Autor: Schubert J; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Lindahl B; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala, Sweden., Melhus H; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Renlund H; Uppsala Clinical Research Center, Uppsala, Sweden., Leosdottir M; Department of Cardiology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden., Yari A; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden., Ueda P; Clinical Epidemiology Division, Department of Medicine, Karolinska Institutet, Stockholm, Sweden., James S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala, Sweden., Reading SR; Amgen, Inc, Thousand Oaks, CA, USA., Dluzniewski PJ; Amgen, Inc, Thousand Oaks, CA, USA., Hamer AW; Amgen, Inc, Thousand Oaks, CA, USA., Jernberg T; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden., Hagström E; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.; Uppsala Clinical Research Center, Uppsala, Sweden.

Publikováno v: European heart journal [Eur Heart J] 2021 Jan 20; Vol. 42 (3), pp. 243-252.

Long-Term Evolocumab in Patients With Familial Hypercholesterolemia.

Autor: Santos RD; Lipid Clinic Heart Institute (InCor), University of São Paulo Medical School Hospital and Hospital Israelita Albert Einstein, São Paulo, Brazil. Electronic address: raul.santos@incor.usp.br., Stein EA; Department of Medicine, Cardiology, University of Chicago Pritzker School of Medicine, Chicago, Illinois., Hovingh GK; Department of Vascular Medicine, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands., Blom DJ; Division of Lipidology and Hatter Institute for Cardiovascular Research in Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa., Soran H; Cardiovascular Trials Unit, Manchester University Hospital NHS Foundation Trust, Manchester, United Kingdom., Watts GF; School of Medicine, Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia, Australia; Lipid Disorders Clinic, Department of Cardiology, Royal Perth Hospital, Perth, Western Australia, Australia., López JAG; Amgen, Thousand Oaks, California., Bray S; Amgen, Thousand Oaks, California., Kurtz CE; Amgen, Thousand Oaks, California., Hamer AW; Amgen, Thousand Oaks, California., Raal FJ; Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.

Publikováno v: Journal of the American College of Cardiology [J Am Coll Cardiol] 2020 Feb 18; Vol. 75 (6), pp. 565-574.

Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial.

Autor: Chen Y; Department of Cardiology, Chinese People's Liberation Army General Hospital, Beijing, China., Yuan Z; First Affiliated Hospital of Xi'an Jiaotong University, Shaanxi, China., Lu J; Department of Endocrinology, Chinese People's Liberation Army General Hospital, Beijing, China., Eliaschewitz FG; CPCLIN/DASA - Centro de Pesquisas Clínicas, São Paulo, Brazil., Lorenzatti AJ; Clinical Research and Cardiology, Instituto Medico DAMIC / Fundación Rusculleda, Córdoba, Argentina., Monsalvo ML; Clinical Development, Amgen Inc., Thousand Oaks, California., Wang N; Clinical Development, Amgen Inc., Thousand Oaks, California., Hamer AW; Clinical Development, Amgen Inc., Thousand Oaks, California., Ge J; Department of Cardiology, Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Jun; Vol. 21 (6), pp. 1464-1473. Date of Electronic Publication: 2019 Apr 14.

Long-Term Treatment With Evolocumab Among Japanese Patients　- Final Report of the OSLER Open-Label Extension Studies.

Autor: Hirayama A; Division of Cardiology, Osaka Police Hospital., Yamashita S; Departments of Community Medicine and Cardiovascular Medicine, Graduate School of Medicine, Osaka University.; Rinku General Medical Center., Ruzza A; Amgen Inc., Inomata H; Amgen Astellas BioPharma K.K., Cyrille M; Amgen Inc., Lu C; Amgen Inc., Hamer AW; Amgen Inc., Yoshida M; Life Science and Bioethics Research Center, Tokyo Medical and Dental University., Kiyosue A; Department of Cardiovascular Medicine, The University of Tokyo Hospital., Teramoto T; Teikyo Academic Research Center, Teikyo University.

Publikováno v: Circulation journal : official journal of the Japanese Circulation Society [Circ J] 2019 Apr 25; Vol. 83 (5), pp. 971-977. Date of Electronic Publication: 2019 Mar 29.

Prevalence of abdominal aortic aneurysm in patients referred for transthoracic echocardiography.

Autor: Majeed K; Department of Cardiology, Dunedin Hospital, Dunedin, New Zealand; Department of Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand., Hamer AW, White SC, Pegg TJ, Wilkins GT, Williams SM, Chen YH, Williams MJ

Publikováno v: Internal medicine journal [Intern Med J] 2015 Jan; Vol. 45 (1), pp. 32-9.